American Assets Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,000
Closed -$108K 177
2017
Q4
$108K Buy
+2,000
New +$109K 0.02% 153

Other funds holding BIVV

American Assets Investment Management's BIVV Position: Q1 2018 in Review

American Assets Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,000 shares — an estimated $108K sold.

American Assets Investment Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $108K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • American Assets Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • American Assets Investment Management sold 2,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $108K.
  • American Assets Investment Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • American Assets Investment Management's Bioverativ Inc. Common Stock position peaked at $108K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on American Assets Investment Management's 13F filing for Q1 2018, filed 2 May 2018.